Tilray Brands vs USANA Health Sciences
TLRY and USNA side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How TLRY and USNA compare
Tilray Brands is the larger company, worth 1.5 times as much as USANA Health Sciences ($359M against $245M).
Tilray Brands grew revenue faster over the last twelve months (15.9% versus −0.78% for USANA Health Sciences).
USANA Health Sciences keeps more of each dollar of sales as profit, with a net margin of −2.3% compared with −17.1% at Tilray Brands.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | TLRY | USNA |
|---|---|---|
| Size and price | ||
| Market cap | $359M | $245M |
| Share price | $2.43 | $13.24 |
| Change, 1 year | −80.2% | −31.7% |
| Change, 5 years | −97.8% | −87.0% |
| Beta (5Y) | 1.53 | 0.65 |
| Employees | 3,595 | 1,570 |
| StockData Score | ||
| Total score | 11 | 11 |
| Valuation score | 3 | 4 (better) |
| Growth score | 3 (better) | 0 |
| Performance score | 3 (better) | 2 |
| Health score | 2 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 0.4× | 0.3× (better) |
| P/B | 0.2× (better) | 0.5× |
| EV/EBITDA | – | 2.3× |
| P/FCF | – | 8.3× |
| FCF yield | – | 12.1% |
| Fair value | $17.55 | $31.52 |
| Margin of safety | 86.2% (better) | 58.0% |
| Growth | ||
| Revenue growth (TTM) | 15.9% (better) | −0.78% |
| Revenue growth, 5Y average | 40.5% (better) | −4.0% |
| Net income growth (TTM) | – | −225% |
| EPS growth (TTM) | – | −231% |
| EPS growth, 5Y average | – | −37.0% |
| Profitability | ||
| Gross margin | 29.1% | 77.3% (better) |
| Operating margin | −9.3% | −0.41% (better) |
| Net margin | −17.1% | −2.3% (better) |
| FCF margin | – | 3.3% |
| Return on equity | −10.4% | −4.0% (better) |
| Return on invested capital | −5.0% | −0.81% (better) |
| Financial health | ||
| Debt / equity | 0.08 (better) | 0.00 |
| Interest coverage | – | −9.4× |
| Current ratio | 1.88 | 2.59 (better) |
| Altman Z-score | −2.23 | 3.50 (better) |
| Piotroski F-score | 3 | 6 (better) |
| Dividends and buybacks | ||
| Buyback yield | −43.9% | 0.00% (better) |
| Shareholder yield | −43.9% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 9.5% | 66.2% |
| Held by insiders | 2.0% | 40.9% |
| Insider net buying, 12 months | −$164K (better) | −$895K |
| Short interest, % of float | 13.5% | 8.1% |
Go deeper
- TLRY stock overview
- TLRY income statement
- TLRY valuation and score
- USNA stock overview
- USNA income statement
- USNA valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.